Amylyx Pharmaceuticals, Inc.

AMLXNASDAQ Global Select·USD·Closed

AMLXNASDAQ·USD·Closed

$20.31

−2.12%

$20.31

−$0.44 (2.12%)

52W Range

95thpctl

Volume

1.13×avg

Mkt Cap

2.26BUSD

P/E

-13.7TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

95thpctl

Volume

1.13×avg

Market Cap

2.26BUSD

P/E Ratio

-13.7TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-77.1% / yr

Operating margin0.0%

ROIC-57.1%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage0.0×

Current ratio17.85×